KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

LifeMD (LFMD) Shares Outstanding (2016 - 2026)

LifeMD filings provide 14 years of Shares Outstanding readings, the most recent being $46.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 10.56% to $46.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $46.8 million, a 10.56% increase, with the full-year FY2025 number at $46.8 million, up 10.56% from a year prior.
  • Shares Outstanding hit $46.8 million in Q4 2025 for LifeMD, roughly flat from $46.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $46.8 million in Q4 2025 to a low of $500000.0 in Q3 2021.
  • Median Shares Outstanding over the past 5 years was $1.4 million (2021), compared with a mean of $17.6 million.
  • The widest YoY moves for Shares Outstanding: up 3234.74% in 2025, down 96.65% in 2025.
  • LifeMD's Shares Outstanding stood at $30.7 million in 2021, then tumbled by 95.44% to $1.4 million in 2022, then changed by 0.0% to $1.4 million in 2023, then soared by 2920.99% to $42.3 million in 2024, then grew by 10.56% to $46.8 million in 2025.
  • The last three reported values for Shares Outstanding were $46.8 million (Q4 2025), $46.7 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.